Breast cancer resources for healthcare providers
About one in 10 women has a family history of breast and/or ovarian cancer that puts her at increased risk of developing these malignancies due to underlying genetic factors. These resources provide opportunities to learn about hereditary breast cancer syndromes, how to use family history to assess risk level, genetic testing, using genetic information to inform management, and communicating with patients about genetic risk.
Hereditary Breast and Ovarian Cancer Syndrome Factsheet. Describes the clinical features, diagnosis, testing and genetics of hereditary breast and ovarian cancer (HBOC) syndrome.
Genetically Related Cancers Tool. Lists the associated cancers and unique characteristics of common cancer susceptibility genes.
Cancer Risk Assessment Tool. Helps identify red flags and stratify cancer risk based on family history.
Breast Cancer Risk and Screening Guidelines Factsheet. Summarizes screening guidelines for patients at average, increased, and high genetic risk for breast cancer.
Communicating Risk Factsheet. Outlines key points to consider when communicating risk to patients.
Pretest Counseling Key Points Factsheet. Outlines key points to address during pretest counseling.
Components of a Cancer Genetic Counseling Session Factsheet. Discusses the core components of a cancer genetic counseling session.
Hereditary Cancer Management Guidelines Factsheet. Lists and links to evidence-based guidelines and professional society publications that address management of hereditary and familial cancer.
Family History Collection Tips & Tools. Provides tips, resources, and tools for family history collection in clinical practice.
Family History Questionnaire. A collection form for medical family history data that can be printed and used in clinical practice.
Pedigree Tool. A template to record a pedigree with standard pedigree nomenclature.
Genetic Testing Methods eBook. Provides information about different genetic testing methods currently used in testing for hereditary cancer syndromes (enhanced e-book available for download).
Accessing Genetic Services Tool. Lists tools and websites to help find genetics professionals and provides patient talking points about referring to genetics.
Cancer Genetic Services in Maine and Connecticut Tool. Lists available cancer genetic services in Maine and Connecticut.
Hereditary Breast Cancer Patient and Family Resources. Provides patient resources for understanding genetic services and breast cancer genetics.
GINA Discussion Guide. Provides talking points and key information about genetic discrimination and the Genetic Information Nondiscrimination Act (GINA), which protects individuals from the misuse of genetic information in health insurance and employment.
Free, self-directed programs for continuing education credit.
Learn how to identify, evaluate, and manage patients at increased risk of HBOC.
Access CME Module
Practice evaluating how well a particular genetic test assesses breast cancer risk and the potential impact of testing on patient outcomes.
Access CME Module | Access CNE Module
Practice asking the right questions to elicit enough information to assess family history disease risk and get tools to implement your skills.
Access CME Module | Access CNE Module
Analyze family histories and classify patients' risk into average, increased (moderate), or high risk for cancer.
Access CME Module | Access CNE Module
Practice determining appropriate management based on family history risk stratification.
Access CME Module | Access CNE Module
Practice identifying risk factors in case scenarios and receive tools to help make this task easy to implement in your practice.
Access CME Module | Access CNE Module
Practice deciding when and if genetic testing is appropriate given a patient's clinical and personal context.
Access CME Module | Access CNE Module
Practice interpreting genetic testing results within a patient's specific context.
Access CME Module | Access CNE Module
Practice weighing the benefits, risks, and limitations of different tests within specific patient contexts.
Access CME Module | Access CNE Module
Join us as we discuss a new onco-hu model of ER+, ESR1-mutant, endocrine-resistant metastatic breast cancer.
Join our live discussion on preclinical efficacy and safety testing for novel antibody-based therapeutics.
We take a look at the history of genomic sequencing, where it's going in the future, and the power it has to potentially treat diseases...
A research team at JAX is boosting the speed and accuracy of tumor sample image analysis, for multiple cancer types,...
Roel Verhaak is leading an international group of clinicians and researchers, investigating why gliomas develop resistance and recur after...
Roel Verhaak has joined the global Cancer Grand Challenges team, receiving $25M to take on the challenge of extrachromosomal...
The new technique of methylome profiling, now available from The Jackson Laboratory, provides more precise tumor classification for cancers...
Using sophisticated labeling methods, a team led by Professor Karolina Palucka, M.D., Ph.D., and Jan Martinek, Ph.D.,...
These breast cancer resources provide health care professionals with education about genetics and breast cancer including family history...
Key features and cancer risks associated with common hereditary cancer syndromes.
Genetic counseling collaboration tool and checklist.
The traditional approach to genetic testing for those of Ashkenazi Jewish ancestry is under debate, with some experts calling for testing...
Newer lines of research are focused on understanding cancer stem (CSC) cell biology so that therapies targeting them can be...
Olga Anczuków, Ph.D., is a breast cancer researcher who investigates how changes in gene regulation contribute to cancer.
Stefanie Stein Jeffrey, M.D., spent time at the Jackson laboratory as a junior high student. She is now both a cancer...
The USPSTF updated this important screening recommendation in August, 2019. It now recommends screening for potentially harmful BRCA1 and...